Education
About Us
Working with TipRanks
Follow Us
Ventas (VTR)
NYSE:VTR
VTR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$56.68 - $71.36
Previous CloseN/A
Volume499.79K
Average Volume (3M)2.77M
Market Cap
$32.08B
Enterprise Value$42.05B
Total Cash (Recent Filing)$614.20M
Total Debt (Recent Filing)$13.27B
Price to Earnings (P/E)159.2
Beta0.33
Next Earnings
Oct 29, 2025EPS Estimate
0.09Last Dividend Ex-Date
Sep 30, 2025Dividend Yield2.78%
Share Statistics
EPS (TTM)0.15
Shares Outstanding454,471,200
10 Day Avg. Volume2,939,971
30 Day Avg. Volume2,765,303
Financial Highlights & Ratios
PEG Ratio-1.00
Price to Book (P/B)2.25
Price to Sales (P/S)4.92
P/FCF Ratio33.41
Enterprise Value/Market Cap1.31
Enterprise Value/Revenue7.93
Enterprise Value/Gross Profit21.89
Enterprise Value/Ebitda20.93
Forecast
1Y Price Target
$76.57Price Target Upside12.60% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
Bulls Say, Bears Say
Bulls Say
Financial PerformanceVTR reaffirmed ~8% SHOP SS revenue growth for FY25.
Investment ActivityVTR closed $1.8bn in senior housing investments YTD, with FY25 investment volume expected at $2.0 billion.
Operational EfficiencyVTR initiated Brookdale NNN-to-SHOP conversions, completing 11 transitions in September, with more expected to enhance operational efficiency.
Bears Say
Debt ManagementVTR raised ~$2.2bn in equity and repaid $425mn of secured debt, improving secured debt/GAV from 8%.
Market ConditionsNew supply is expected to remain muted given acquisitions at discount to replacement costs.
Ventas News
VTR FAQ
What was Ventas’s price range in the past 12 months?
Ventas lowest stock price was $56.68 and its highest was $71.36 in the past 12 months.
What is Ventas’s market cap?
Ventas’s market cap is $32.08B.
When is Ventas’s upcoming earnings report date?
Ventas’s upcoming earnings report date is Oct 29, 2025 which is in 19 days.
How were Ventas’s earnings last quarter?
Ventas released its earnings results on Jul 30, 2025. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.135 by $0.015.
Is Ventas overvalued?
According to Wall Street analysts Ventas’s price is currently Undervalued.
Does Ventas pay dividends?
Ventas pays a Quarterly dividend of $0.48 which represents an annual dividend yield of 2.78%. See more information on Ventas dividends here
What is Ventas’s EPS estimate?
Ventas’s EPS estimate is 0.09.
How many shares outstanding does Ventas have?
Ventas has 454,471,200 shares outstanding.
What happened to Ventas’s price movement after its last earnings report?
Ventas reported an EPS of $0.15 in its last earnings report, beating expectations of $0.135. Following the earnings report the stock price went up 1.045%.
Which hedge fund is a major shareholder of Ventas?
Currently, no hedge funds are holding shares in VTR
Ventas Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$76.57 (12.60% Upside)
$76.57 (12.60% Upside)
Blogger Sentiment
Bullish
VTR Sentiment 80%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 458.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 3.5%
Last 30 Days ▲ 3.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.25%
12-Months-Change
Fundamentals
Return on Equity
1.81%
Trailing 12-Months
Asset Growth
7.93%
Trailing 12-Months
Company Description
Ventas
Ventas, Inc. (VTR) is a leading real estate investment trust (REIT) based in the United States, primarily focused on the healthcare sector. The company owns and operates a diverse portfolio of properties, including senior housing communities, medical office buildings, and post-acute care facilities. Ventas aims to provide long-term value to its shareholders through strategic investments and management of high-quality healthcare real estate across various geographic markets.
VTR Company Deck
VTR Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with significant growth in SHOP and outpatient medical segments, alongside an increase in investment guidance. However, challenges remain with the headwinds from post-acute asset dispositions and a competitive acquisition market. Overall, the call presents a positive outlook with some caution regarding specific segments.View all VTR earnings summariesVTR Revenue Breakdown
68.49% SHOP
17.82% OM&R
12.63% NNN
1.05% Non-Segment
VTR Stock 12 Month Forecast
Average Price Target
$76.57
▲(12.60% Upside)
Technical Analysis
Healthpeak Properties
―
Welltower
―
Omega Healthcare
―
Sabra Healthcare REIT
―
Healthcare Realty Trust
―
Ownership Overview
0.46% Insiders
29.32% Mutual Funds
16.52% Other Institutional Investors
22.68% Public Companies and
Individual Investors